Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Eastman Chemical
EMN
$8.43B
| $96M | 0.02% |
1,051,397
+387,513
| +58% | +$39.7M |
|
752
Credo Technology Group
CRDO
$49.6B
| $95.9M | 0.02% |
1,426,508
+59,848
| +4% | +$2.97M |
|
753
PUT
Okta
OKTA
$26.9B
| $95.8M | 0.02% |
1,215,300
+351,200
| +41% | +$27.2M |
|
754
CALL
iShares MSCI Japan ETF
EWJ
$23.2B
| $95.7M | 0.02% |
1,426,000
-482,700
| -25% | -$33.3M |
|
|
AXON
755
Axon Enterprise
AXON
$50B
| $95.4M | 0.02% |
160,516
-7,321
| -4% | -$3.98M |
|
756
PUT
Teva Pharmaceuticals
TEVA
$42.6B
| $95.3M | 0.02% |
4,325,400
+3,800,300
| +724% | +$69.1M |
|
757
CALL
D.R. Horton
DHI
$41.9B
| $95.2M | 0.02% |
681,200
-25,900
| -4% | -$4.33M |
|
758
CACI
CACI
$14.8B
| $95.1M | 0.02% |
235,438
+202,269
| +610% | +$98.6M |
|
759
Vornado Realty Trust
VNO
$7.41B
| $95.1M | 0.02% |
2,261,671
-886,043
| -28% | -$37.5M |
|
760
PUT
Expedia Group
EXPE
$39.4B
| $94.9M | 0.02% |
509,300
+79,800
| +19% | +$13.8M |
|
761
Cigna
CI
$73.5B
| $94.9M | 0.02% |
343,534
+121,147
| +54% | +$38.6M |
|
762
Sun Communities
SUI
$14.6B
| $94.7M | 0.02% |
769,901
+146,599
| +24% | +$18.8M |
|
763
Chord Energy
CHRD
$7.35B
| $94.6M | 0.02% |
809,486
+590,739
| +270% | +$74.3M |
|
764
PUT
Union Pacific
UNP
$177B
| $94.6M | 0.02% |
414,800
+13,900
| +3% | +$3.29M |
|
765
CALL
On Holding
ONON
$10.6B
| $94.6M | 0.02% |
1,726,600
+71,000
| +4% | +$3.76M |
|
766
Legend Biotech
LEGN
$3.93B
| $94.5M | 0.02% |
2,904,857
+1,588,303
| +121% | +$65.8M |
|
767
Booking.com
BKNG
$160B
| $94.5M | 0.02% |
475,400
-1,254,400
| -73% | -$241M |
|
768
CALL
Elevance Health
ELV
$86.4B
| $94.5M | 0.02% |
256,100
+82,900
| +48% | +$34.7M |
|
|
769
CALL
Cigna
CI
$73.5B
| $93.9M | 0.02% |
340,000
+99,300
| +41% | +$31.7M |
|
770
Ross Stores
ROST
$78.6B
| $93.8M | 0.02% |
+619,756
| New | +$91.1M |
|
771
CALL
ProShares UltraPro Short QQQ
SQQQ
$1.67B
| $93.6M | 0.02% |
601,376
+455,092
| +311% | +$75.9M |
|
772
CALL
Fortinet
FTNT
$121B
| $93.6M | 0.02% |
990,400
-111,500
| -10% | -$9.92M |
|
773
CALL
Direxion Daily Financial Bull 3x ETF
FAS
$2.5B
| $93.5M | 0.02% |
619,600
+11,000
| +2% | +$1.7M |
|
774
Roku
ROKU
$22.9B
| $93.2M | 0.02% |
1,253,947
-365,386
| -23% | -$27.7M |
|
775
VF Corp
VFC
$5.79B
| $92.9M | 0.02% |
4,328,503
+991,815
| +30% | +$20.2M |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.